used in standard Chinese, Ayurvedic, and Thai medication. Conolidine could characterize the start of a whole new period of chronic pain administration. It's now getting investigated for its effects within the atypical chemokine receptor (ACK3). Within a rat model, it was discovered that a competitor molecule binding to ACKR3 resulted in inhibition